Immunohistochemical analysis demonstrated 45.6% and 40.0% reductions in STAT3<sup>+</sup> (<i>P</i> = 0.01) and STAT5<sup>+</sup> (<i>P</i> = 0.0478) tumor cells, respectively. The gene discussed is STAT3; the disease is neoplasm.